What it is
This is a combination capsule holding three compounds at fixed amounts: Dihexa 5 mg, Methylene Blue 50 mg, and Tesofensine 500 mcg. A mcg is a microgram, one thousandth of a milligram (mg).
Dihexa (also written N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, or PNB-0408) is a nootropic — a compound taken to improve thinking. It was developed for Alzheimer's and Parkinson's disease, and is also said to improve stroke recovery, speeds recovery from spinal cord and nerve injury, and protects against hearing loss. What makes it unusual is that it does not just slow damage down; it repairs the synapse, the junction where one nerve cell passes a signal to the next. It works by binding HGF (hepatocyte growth factor), a signalling protein that drives cell growth and repair, increasing its activity while lowering harmful chemical reactions — which is said to double what the growth factors already present can do.
Methylene Blue (methylthioninium chloride) is a synthetic dye long used as a stain in laboratories and in many industrial and medical applications. The World Health Organization has it on its List of Essential Medicines, meaning it is considered vital for a basic health system. Inside cells it can carry electrons through the energy-producing chain in mitochondria — the tiny structures that turn food into usable energy — bypassing faults in that chain.
Tesofensine (NS2330) is a triple reuptake inhibitor. Nerve cells communicate using chemical messengers; after a message is sent, the cell normally reabsorbs the messenger. Tesofensine blocks that reabsorption for three of them — serotonin, norepinephrine, and dopamine — so more remains active. It was first researched as an add-on for Alzheimer's treatment and became known as a weight loss drug once its effects on weight became clear. It is reported to produce an average 10% weight loss within 24 weeks, and to raise blood pressure by 1 to 3 mmHg (millimetres of mercury, the unit blood pressure is measured in) and heart rate by up to 8 beats per minute.
Read the who-should-avoid section before you take this. Methylene Blue blocks an enzyme called MAO-A. Tesofensine must not be used with MAO inhibitors. Both are in this capsule, and that conflict has not been resolved.
Fixed-ratio oral combination: dihexa 5 mg + methylene blue 50 mg + tesofensine 500 mcg per capsule.
Dihexa is an angiotensin IV analogue and orally active, blood-brain-barrier-penetrant neurotrophic agent that potentiates hepatocyte growth factor signalling through the HGF/c-MET axis, producing synaptogenesis rather than neurotransmitter modulation.
Methylene blue is a phenothiazinium redox dye that accepts electrons from NADH and donates them to cytochrome c, bypassing complexes I and III of the mitochondrial respiratory chain. It is lipophilic, crosses the blood-brain barrier readily, and is a potent reversible MAO-A inhibitor.
Tesofensine (NS2330) is a serotonin-noradrenaline-dopamine triple reuptake inhibitor, originally an Alzheimer's adjunct, repurposed for weight loss. Reported mean weight loss is ~10% at 24 weeks, with blood pressure raised 1–3 mmHg and heart rate up to 8 bpm.
The pharmacological problem is explicit and unresolved: methylene blue is an MAO-A inhibitor; tesofensine blocks serotonin reuptake; tesofensine's own "High Risk: Do Not Use" list opens with MAO inhibitors, and its contraindications include MAOI use within the previous 14 days. Combining an MAOI with a serotonin reuptake inhibitor is the canonical serotonin syndrome pairing, and the methylene blue safety data warn about exactly that. No resolution of this conflict has been offered.
At 50 mg, the methylene blue content is also double the 25 mg standalone page's dose.
What it does
Three different things at once, which is the point of the combination.
Dihexa builds new connections between brain cells, improving memory and learning, and raises production of acetylcholine and dopamine — two of the chemical messengers nerve cells use. It also protects nerve cells and increases blood flow to the brain.
Methylene Blue improves how mitochondria produce energy, acts as an antioxidant (neutralising free radicals, the unstable molecules that damage cells), adjusts nitric oxide levels which affects blood flow, protects nerve cells, increases blood flow to the brain, and disrupts the workings of bacteria and other microbes.
Tesofensine raises serotonin, norepinephrine, and dopamine. That drives appetite suppression and weight loss, but also affects mood, energy, sleep, and blood sugar.
So the combination is: build the brain's wiring, power the cells that wiring runs on, and turn up the messengers travelling through it — with weight loss as the third compound's main effect.
The practical instruction is one capsule in the morning, best taken with a light meal containing a small amount of protein and fat, avoiding heavy carbohydrates.
Three mechanisms in one capsule.
Dihexa: synaptogenesis through HGF/c-MET potentiation, increased acetylcholine and dopamine production, HGF-mediated neuroprotection, increased cerebral blood flow.
Methylene blue: respiratory-chain electron shuttling bypassing complex deficiency, direct antioxidant activity, nitric oxide modulation with cardiovascular consequences, neuroprotection, cognitive enhancement via increased cerebral blood flow, and antimicrobial disruption of bacterial function.
Tesofensine: serotonin, noradrenaline, and dopamine reuptake inhibition, raising synaptic levels of all three. Attributed to that are weight loss, cognitive improvement, mood stabilisation, glycaemic improvement, increased resting energy expenditure, thermogenesis, and increased BDNF to that.
Read together, the dopaminergic loading is the thing to watch: dihexa increases dopamine production, methylene blue inhibits its degradation route through MAO, and tesofensine blocks its reuptake. Three points on the same pathway, in one capsule, with no titration.
Administration: one capsule in the morning with a light meal containing a small amount of protein and fat, avoiding heavy carbohydrate. No cycle length is given.
Benefits
Evidence grades: what the labels mean
- Human trials Supported by randomised or placebo-controlled human trials.
- Limited human data Some human evidence, such as pilot studies, case reports or observational data, but no controlled trials.
- Animal or lab only Shown in animal or cell studies only; not yet tested in people.
- Anecdotal No published studies; based on user reports or theory.
Each grade reflects the strongest published support for that specific claim, not for the compound as a whole.
- Benefits are grouped by compound below, starting with Dihexa: aids in the treatment of Alzheimer's and Parkinson's diseases.Animal or lab only
- Dihexa: improves thinking, particularly memory retention and the ability to learn.Animal or lab only
- Dihexa: improves stroke recovery.Anecdotal
- Dihexa: speeds up recovery from spinal cord injury and nerve damage.Anecdotal
- Dihexa: protects against hearing loss.Anecdotal
- Dihexa: aids in treating memory and movement problems by forming new working synapses — the junctions where one nerve cell passes a signal to the next.Animal or lab only
- Dihexa: builds new brain cell connections.Animal or lab only
- Dihexa: prevents learning and memory problems after sustained cerebral ischaemia (periods of reduced blood flow to the brain) by protecting brain nerve cells from injury.Anecdotal
- Dihexa: increases production of acetylcholine and/or dopamine.Anecdotal
- Dihexa: activates HGF, which produces long-term protection of nerve cells and helps stroke recovery.Anecdotal
- Dihexa: prevents stroke by increasing blood flow to the brain.Anecdotal
- Dihexa: slows the progression of spinal cord injury caused by ALS (amyotrophic lateral sclerosis), and helps heal damage to the sciatic nerve.Anecdotal
- Methylene Blue: helps electrons move through the energy-producing chain in mitochondria, bypassing certain faults in it and reducing oxidative stress — improving mitochondrial function, boosting cellular energy production, and potentially helping conditions where brain cells break down.Animal or lab only
- Methylene Blue: acts as an antioxidant, neutralising harmful free radicals that damage cells and contribute to ageing and disease.Animal or lab only
- Methylene Blue: adjusts nitric oxide levels, with positive implications for heart health and blood flow.Animal or lab only
- Methylene Blue: protects nerve cells by keeping them alive and functioning, potentially reducing the risk of neurodegenerative disorders.Animal or lab only
- Methylene Blue: improves thinking by increasing blood flow to the brain and improving memory and attention.Limited human data
- Methylene Blue: its antimicrobial properties disrupt how bacteria and microbes work, making it an effective addition to standard antimicrobial treatment.Limited human data
- Methylene Blue: dissolves in fat, so it crosses the barrier protecting the brain efficiently, with high brain concentrations seen after a dose.Animal or lab only
- Methylene Blue: counteracts cells ageing before their time.Animal or lab only
- Methylene Blue: reduces markers of ageing in body tissues.Animal or lab only
- Methylene Blue: reduces ABAD (amyloid-binding alcohol dehydrogenase), which damages brain cells, while raising levels of estradiol.Animal or lab only
- Methylene Blue: helps ease symptoms of hepatic encephalopathy — loss of brain function caused by toxins building up because of liver damage.Anecdotal
- Methylene Blue: works with macroautophagy, the cell's process for recycling its own worn-out parts, to stop brain cells dying when short of nutrients.Animal or lab only
- Methylene Blue: is an antidote for cyanide or carbon monoxide poisoning.Limited human data
- Methylene Blue: helps treat urinary tract infections.Limited human data
- Methylene Blue: reduces the death rate in people with low blood pressure after heart surgery (postoperative vasoplegia).Human trials
- Methylene Blue: used in the management of septic shock.Human trials
- Methylene Blue: drastically reduces harm and deaths in children with shock that has not responded to fluid and catecholamine therapy.Limited human data
- Methylene Blue: increases mean arterial pressure, which in septic shock reduces the need for other medications, shortens hospital stays, and improves heart function and oxygen levels.Human trials
- Methylene Blue: can treat psychotic and mood disorders, improve memory in fear-extinction training, and shows promise in short- and long-term bipolar treatment, with antidepressant and anti-anxiety effects and without triggering manic episodes.Limited human data
- Methylene Blue: increases the growth of skin fibroblasts and delays their ageing; applied to skin it improves skin viability, wound healing, hydration, thickness of the deeper skin layer, and the genes governing the skin's structural proteins.Animal or lab only
- Methylene Blue: shows superior absorption of UVA and UVB light and protects against DNA damage.Animal or lab only
- Methylene Blue: for people with chronic idiopathic pruritus ani that has not responded to standard treatment, injections of a 1% solution resolved symptoms within four weeks.Limited human data
- Methylene Blue: effective in treating malaria, urinary tract infections, shock, and methemoglobinemia. It is described as the only known substance able to restrain excessive production of reactive species and cytokines, and suggests potential in COVID-19 and SARS-CoV-2.Anecdotal
- Methylene Blue: a particularly effective antiviral for flavivirus infections, especially Zika virus.Animal or lab only
- Methylene Blue: is an anticancer agent and promotes apoptosis (programmed cell death) in tumours.Animal or lab only
- Methylene Blue: for patients with oral mucositis, a painful complication of cancer therapy, rinsing with it significantly reduced pain within the first three treatments.Limited human data
- Methylene Blue: helps treat methemoglobinemia, a condition in which the blood cannot carry oxygen properly.Human trials
- Tesofensine: promotes weight loss.Human trials
- Tesofensine: improves thinking.Anecdotal
- Tesofensine: stabilises mood.Anecdotal
- Tesofensine: improves blood sugar levels.Limited human data
- Tesofensine: treats sexual dysfunction.Anecdotal
- Tesofensine: treats eating disorders.Anecdotal
- Tesofensine: treats ADHD.Anecdotal
- Tesofensine: improves sleep quality.Anecdotal
- Tesofensine: combats alcohol addiction.Anecdotal
- Tesofensine: enhances erections.Anecdotal
- Tesofensine: improves insulin sensitivity.Limited human data
- Tesofensine: increases resting energy expenditure.Limited human data
- Tesofensine: reduces fat oxidation, as it is sometimes worded. That contradicts the claims around it — increased thermogenesis, increased resting energy expenditure, reduced fat tissue — so it reads as a transcription error rather than a real claim.Anecdotal
- Tesofensine: reduces fat tissue.Human trials
- Tesofensine: improves sex drive.Anecdotal
- Tesofensine: improves memory.Anecdotal
- Tesofensine: increases thermogenesis — the burning of energy as heat.Limited human data
- Tesofensine: may be used to treat brain disorders such as Alzheimer's and Parkinson's.Anecdotal
- Tesofensine: increases levels of BDNF (brain-derived neurotrophic factor, a protein that supports nerve cell growth), which triggers an antidepressant effect.Animal or lab only
- Benefits enumerated per component, grouped below, beginning with Dihexa: treatment of Alzheimer's and Parkinson's disease.Animal or lab only
- Dihexa: improved cognitive function, particularly memory retention and learning ability.Animal or lab only
- Dihexa: improved stroke recovery.Anecdotal
- Dihexa: accelerated recovery from spinal cord injury and nerve damage.Anecdotal
- Dihexa: protection against hearing loss.Anecdotal
- Dihexa: treatment of memory and motor dysfunction through enhanced synaptic connectivity via formation of new functional synapses.Animal or lab only
- Dihexa: formation of new neuronal connections.Animal or lab only
- Dihexa: prevention of learning and memory dysfunction after sustained cerebral ischaemia.Anecdotal
- Dihexa: increased acetylcholine and/or dopamine production.Anecdotal
- Dihexa: HGF activation inducing long-term neuroprotection and stroke recovery.Anecdotal
- Dihexa: stroke prevention via increased cerebral blood flow.Anecdotal
- Dihexa: slowed progression of ALS-related spinal cord injury; healing of sciatic nerve damage.Anecdotal
- Methylene Blue: facilitated electron transfer in the mitochondrial respiratory chain, bypassing complex deficiencies, reducing oxidative stress, improving mitochondrial function and cellular energy production with therapeutic potential in neurodegeneration.Animal or lab only
- Methylene Blue: direct antioxidant activity against free radicals.Animal or lab only
- Methylene Blue: nitric oxide modulation with cardiovascular and blood-flow implications.Animal or lab only
- Methylene Blue: neuroprotection through preservation of neuronal viability and function.Animal or lab only
- Methylene Blue: cognitive enhancement via increased cerebral blood flow, improved memory and attention.Limited human data
- Methylene Blue: antimicrobial disruption of bacterial and microbial function as an adjunct to conventional therapy.Limited human data
- Methylene Blue: lipophilicity permitting efficient blood-brain barrier penetration, with high observed brain concentration.Animal or lab only
- Methylene Blue: counteracts premature cellular senescence and ageing.Animal or lab only
- Methylene Blue: reduces markers of ageing in cellular tissue.Animal or lab only
- Methylene Blue: reduces amyloid-binding alcohol dehydrogenase (ABAD) while increasing estradiol.Animal or lab only
- Methylene Blue: mitigates hepatic encephalopathy symptoms.Anecdotal
- Methylene Blue: acts through macroautophagy to protect neurons under nutrient deprivation.Animal or lab only
- Methylene Blue: antidote for cyanide and carbon monoxide poisoning.Limited human data
- Methylene Blue: treatment of urinary tract infections.Limited human data
- Methylene Blue: reduces mortality in postoperative vasoplegic syndrome.Human trials
- Methylene Blue: septic shock management.Human trials
- Methylene Blue: substantially reduces morbidity and mortality in paediatric shock refractory to fluid and catecholamine therapy.Limited human data
- Methylene Blue: increases mean arterial pressure in septic shock, reducing adjunct medication requirement and length of stay, improving cardiac function and oxygenation.Human trials
- Methylene Blue: treatment of psychotic and mood disorders; memory enhancement in fear-extinction training; promise in bipolar treatment with antidepressant and anxiolytic effects and no mania induction.Limited human data
- Methylene Blue: enhanced dermal fibroblast proliferation and delayed senescence; topically improves skin viability, wound healing, hydration, dermal thickness, and extracellular matrix gene expression.Animal or lab only
- Methylene Blue: superior UVA/UVB absorption with protection against DNA damage.Animal or lab only
- Methylene Blue: chronic refractory idiopathic pruritus ani resolved within four weeks with intradermal 1% solution.Limited human data
- Methylene Blue: efficacy in malaria, UTI, shock, and methemoglobinemia; described as uniquely able to restrain excessive reactive-species and cytokine generation, with suggested COVID-19 and SARS-CoV-2 application.Anecdotal
- Methylene Blue: antiviral activity against flaviviruses, particularly Zika.Animal or lab only
- Methylene Blue: anticancer activity promoting tumour apoptosis.Animal or lab only
- Methylene Blue: significant oral mucositis pain reduction within three rinse treatments.Limited human data
- Methylene Blue: treatment of methemoglobinemia.Human trials
- Tesofensine: weight loss.Human trials
- Tesofensine: improved cognitive function.Anecdotal
- Tesofensine: mood stabilisation.Anecdotal
- Tesofensine: improved blood glucose.Limited human data
- Tesofensine: treatment of sexual dysfunction.Anecdotal
- Tesofensine: treatment of eating disorders.Anecdotal
- Tesofensine: treatment of ADHD.Anecdotal
- Tesofensine: improved sleep quality.Anecdotal
- Tesofensine: combats alcohol addiction.Anecdotal
- Tesofensine: enhanced erections.Anecdotal
- Tesofensine: improved insulin sensitivity.Limited human data
- Tesofensine: increased resting energy expenditure.Limited human data
- Tesofensine: reduced fat oxidation, as sometimes worded — which reads as a transcription error against the rest of the list, since increased oxidation is what the mechanism and the surrounding claims imply.Anecdotal
- Tesofensine: reduced fat tissue.Human trials
- Tesofensine: improved libido.Anecdotal
- Tesofensine: improved memory.Anecdotal
- Tesofensine: increased thermogenesis.Limited human data
- Tesofensine: potential use in Alzheimer's and Parkinson's disease.Anecdotal
- Tesofensine: increased BDNF, producing an antidepressant effect.Animal or lab only
Reconstitution and dosing
One capsule per day, in the morning. Each capsule holds Dihexa 5 mg, Methylene Blue 50 mg, and Tesofensine 500 mcg.
It is best taken with a light meal containing a small amount of protein and fat, and to avoid heavy carbohydrates. That differs from every one of the three standalone pages: Dihexa says take it on an empty stomach, and Methylene Blue says lightly fasted.
There is no build-up. You start at the full dose of all three compounds on day one.
No cycle length or washout period has been established for this blend. For comparison, the standalone pages run 8 to 12 weeks for Dihexa and 4 to 8 weeks for Methylene Blue.
Two dose comparisons worth knowing. The Methylene Blue here is 50 mg, double the 25 mg on the standalone Methylene Blue page. The Dihexa at 5 mg is the lowest dose on its own page's 5 to 20 mg range, and the Tesofensine at 500 mcg matches its standalone page exactly.
Fixed ratio: dihexa 5 mg + methylene blue 50 mg + tesofensine 500 mcg, one capsule daily, morning.
Administration: with a light meal containing a small amount of protein and fat, avoiding heavy carbohydrate. This directly contradicts both the standalone dihexa page (empty stomach, 30-minute wait before eating) and the standalone methylene blue page (lightly fasted for maximum mitochondrial and cognitive benefit). No reason for the change has been given.
No titration. All three components start at full dose simultaneously — notable given that the tesofensine and methylene blue arms both carry dose-sensitive cardiovascular and neuroexcitatory profiles.
No cycle length or washout is stated. The component pages give 8–12 weeks on / 4–6 off for dihexa and 4–8 weeks on / 2–4 off for methylene blue; the shorter of the two would be the conservative read.
Dose comparison against standalone pages: methylene blue 50 mg is 2× the standalone 25 mg pill; dihexa 5 mg is the bottom of its 5–20 mg range; tesofensine 500 mcg matches its standalone pill exactly. So the methylene blue arm — the MAO-A inhibitor — is the one dosed above its own page's level, in a capsule that also contains a serotonin reuptake inhibitor.
Capsules — Dihexa 5 mg + Methylene Blue 50 mg + Tesofensine 500 mcg per capsule
Cycle: Not established — no cycle length or washout period is defined for this blend · Frequency: Once per day, in the morning. Best taken with a light meal containing a small amount of protein and fat; avoid heavy carbohydrates
| When | Dose | How often |
|---|---|---|
| Standard dosing | 1 capsule (5 mg + 50 mg + 500 mcg) | once per day, in the morning |
Who should avoid it
- Start here: this capsule contains Methylene Blue, which blocks the enzyme MAO-A, and Tesofensine, which must not be used with MAO inhibitors and lists MAOI use within the previous 14 days as a contraindication. These two facts have never been reconciled. Combining a drug that blocks MAO with a drug that raises serotonin is the classic cause of serotonin syndrome, and both component sections on this page warn about serotonin syndrome separately. Do not take this without a doctor's involvement.
- The rest of the list is grouped by compound, starting with the Dihexa contraindications: a history of metastatic cancer — cancer that has spread from where it started.
- Dihexa contraindications: precancerous lesions being monitored.
- Dihexa contraindications: pregnancy or breastfeeding, because there is no safety data.
- Dihexa contraindications: children.
- Dihexa, use only with caution and under close medical supervision: bipolar disorder or severe anxiety disorders; epilepsy or a history of seizures; brain tumours; retinal vascular disease (disease of the blood vessels at the back of the eye); autoimmune disease affecting the brain and spinal cord.
- Dihexa interactions: other strong nerve-growth compounds — namely Cerebrolysin, Semax and NA-Semax, Selank, NSI-189, stacks that raise BDNF, and high doses of Lion's Mane. Possible reactions include anxiety, insomnia, and overexcited nerve activity.
- Dihexa interactions: dopamine-raising drugs. Possible amplification of stimulants such as amphetamine and methylphenidate, plus bromantane and MAO inhibitors. Possible reactions include agitation, insomnia, and activation of the fight-or-flight response.
- Dihexa interactions: growth-factor and regenerative peptides — a theoretical adding-up of growth signals with IGF-1 LR3, growth hormone secretagogues such as CJC-1295 and Ipamorelin, TB-500, and BPC-157.
- Dihexa interactions: anti-cancer therapies — possible working-against of c-MET inhibitors (c-MET is the receptor that HGF switches on, and some cancer drugs work by blocking it) and of chemotherapy that relies on suppressing cell growth.
- Methylene Blue contraindications: pregnancy or breastfeeding.
- Methylene Blue contraindications: G6PD deficiency — glucose-6-phosphate dehydrogenase deficiency, a genetic condition that stops red blood cells protecting themselves from oxidative stress, creating a risk of red blood cells being destroyed.
- Methylene Blue contraindications: active or recent use of SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), tricyclic antidepressants, or MAO inhibitors — all classes of antidepressant — because combining them can cause serotonin syndrome.
- Methylene Blue contraindications: severe liver or kidney disease or dysfunction, because those organs cannot break the compound down and clear it.
- Methylene Blue interactions: serotonin-raising drugs — SSRIs, SNRIs, tricyclic antidepressants, and MAOIs — can cause serotonin syndrome.
- Methylene Blue interactions: antidepressants. Because it blocks MAO-A, combining it with an MAO inhibitor such as phenelzine or tranylcypromine raises the risk of a hypertensive crisis (a dangerous blood pressure spike) as well as serotonin syndrome.
- Methylene Blue interactions: other MAO inhibitors, including ones not used as antidepressants such as selegiline — same risks.
- Methylene Blue interactions: blood thinners and antiplatelet drugs. It may affect how platelets clump and how blood clots, so take care with warfarin or heparin; this is more common with intravenous use.
- Methylene Blue interactions: stimulant drugs acting on adrenaline pathways such as epinephrine, dopamine, amphetamine, or pseudoephedrine — increased risk of high blood pressure and a fast heart rate.
- Methylene Blue interactions: drugs affecting the liver enzyme CYP1A2. It is broken down by that enzyme, so drugs that block it (ciprofloxacin) or speed it up (carbamazepine) change its levels.
- Methylene Blue interactions: dantrolene, used for malignant hyperthermia — Methylene Blue can make it less effective.
- Methylene Blue interactions: caffeine — the two add up in stimulating the nervous system, making nervousness, insomnia, or a fast heart rate more likely.
- Tesofensine contraindications: pregnancy or breastfeeding.
- Tesofensine contraindications: MAO inhibitor use within the previous 14 days.
- Tesofensine contraindications: uncontrolled high blood pressure.
- Tesofensine contraindications: significant heart or blood vessel disease.
- Tesofensine contraindications: a recent stroke or heart attack.
- Tesofensine contraindications: severe arrhythmias — dangerously irregular heartbeats.
- Tesofensine contraindications: untreated overactive thyroid.
- Tesofensine contraindications: a history of serotonin syndrome.
- Tesofensine contraindications: severe anxiety disorder.
- Tesofensine contraindications: active psychosis or bipolar mania.
- Tesofensine, high risk — do not use: MAO inhibitors such as phenelzine, tranylcypromine, high-dose selegiline, isocarboxazid, and linezolid.
- Tesofensine, high risk — do not use: severe psychiatric instability, meaning active psychosis, bipolar mania, severe anxiety disorders, or uncontrolled mania.
- Tesofensine, high risk — do not use: pregnancy or breastfeeding.
- Tesofensine, high risk — do not use: stimulant drugs acting on adrenaline pathways such as amphetamines, phentermine, methylphenidate, ephedrine, and high caffeine intake — these may cause a fast heart rate, high blood pressure, irregular heartbeat, anxiety, and panic.
- Tesofensine, high risk — do not use: GLP medications — the family of appetite-suppressing drugs that act on the gut hormone GLP-1 (glucagon-like peptide-1). GLP medications should not be combined with each other.
- Tesofensine, moderate risk — use with extreme caution under close medical supervision: compounds acting on the GLP-1, GIP, or glucagon receptors. GIP stands for glucose-dependent insulinotropic polypeptide, a second gut hormone that many of these drugs target alongside GLP-1. The risks are excessive appetite suppression, worse nausea, dehydration, and a fast resting heart rate.
- Tesofensine, moderate risk: growth hormone secretagogues such as Ipamorelin, Sermorelin, Tesamorelin, and CJC-1295 — monitor your fasting blood sugar and sleep quality, and watch for cortisol activation.
- Tesofensine, moderate risk: IGF-1 LR3 — watch for unstable blood sugar, disordered appetite, and headaches.
- Tesofensine, moderate risk: stimulating or nerve-active peptides, with Dihexa named here alongside Semax, Selank, and Cerebrolysin — the effects on dopamine add up, leading to anxiety and over-focus. Note that Dihexa is in this very capsule.
- Tesofensine, moderate risk: thyroid-active compounds — the metabolic stimulation adds up and may cause palpitations, heat intolerance, and excessive weight loss.
- Tesofensine, use with caution under close medical supervision: controlled high blood pressure; a resting heart rate above 90 beats per minute; insomnia disorders; ADHD medications; anxiety disorders; migraine disorders; poorly controlled diabetes.
- Tesofensine, serotonin syndrome. This is a serious reaction caused by medications building up high levels of serotonin, ranging from mild (shivering, diarrhoea) to severe (muscle rigidity, fever, seizures, death), most often caused by combining two serotonin-raising medications. Some illegal drugs and dietary supplements are associated with it too.
- Tesofensine, serotonin syndrome symptoms: agitation or restlessness, insomnia, confusion, rapid heart rate and high blood pressure, dilated pupils, loss of muscle coordination or twitching muscles, heavy sweating, diarrhoea, headache, shivering, and goosebumps.
- Tesofensine, signs of severe serotonin syndrome: high fever, tremor, seizures, irregular heartbeat, and unconsciousness.
- Tesofensine, drugs that could cause serotonin syndrome — SNRIs, antidepressants such as desvenlafaxine (Pristiq), levomilnacipran (Fetzima), milnacipran (Savella), duloxetine (Cymbalta, Drizalma Sprinkle), and venlafaxine (Effexor XR).
- Tesofensine, drugs that could cause serotonin syndrome — SSRIs, antidepressants such as citalopram (Celexa), fluoxetine (Prozac), fluvoxamine (Luvox), escitalopram (Lexapro), paroxetine (Paxil, Pexeva, Brisdelle), and sertraline (Zoloft).
- Tesofensine, drugs that could cause serotonin syndrome — bupropion (Zyban, Wellbutrin SR, Wellbutrin XL), an antidepressant and stop-smoking medication.
- Tesofensine, drugs that could cause serotonin syndrome — tricyclic antidepressants such as amitriptyline and nortriptyline (Pamelor).
- Tesofensine, drugs that could cause serotonin syndrome — MAO inhibitors, antidepressants such as isocarboxazid (Marplan) and phenelzine (Nardil).
- Tesofensine, drugs that could cause serotonin syndrome — anti-migraine medications such as carbamazepine (Tegretol, Carbatrol), valproic acid, and triptans including almotriptan, naratriptan (Amerge), and sumatriptan (Imitrex, Tosymra).
- Tesofensine, drugs that could cause serotonin syndrome — pain medications, including opioids such as codeine, fentanyl (Duragesic, Abstral), hydrocodone (Hysingla ER), meperidine (Demerol), oxycodone (Oxycontin, Roxicodone), and tramadol (Ultram, ConZip).
- Tesofensine, drugs that could cause serotonin syndrome — lithium (Lithobid), a mood stabiliser.
- Tesofensine, drugs that could cause serotonin syndrome — illegal drugs including LSD, ecstasy, cocaine, and amphetamines.
- Tesofensine, drugs that could cause serotonin syndrome — herbal supplements including St John's wort, ginseng, and nutmeg.
- Tesofensine, drugs that could cause serotonin syndrome — over-the-counter cough and cold medicines containing dextromethorphan (Delsym).
- Tesofensine, drugs that could cause serotonin syndrome — anti-nausea medications such as granisetron (Sancuso, Sustol), metoclopramide (Reglan), droperidol (Inapsine), and ondansetron (Zofran).
- Tesofensine, drugs that could cause serotonin syndrome — linezolid (Zyvox), an antibiotic.
- Tesofensine, drugs that could cause serotonin syndrome — ritonavir (Norvir), an anti-retroviral medicine used for HIV.
- Talk to a doctor before starting, and go through your full medication list with them. This is the most interaction-heavy product on this site.
- Lead item, and it is a direct conflict in the component data rather than an inference: methylene blue is a potent MAO-A inhibitor, the tesofensine section's "High Risk: Do Not Use" list opens with MAO inhibitors, and its contraindications include MAOI use within the previous 14 days. All three are documented and none has been reconciled. An MAOI plus a serotonin reuptake inhibitor in a single fixed-dose capsule is the canonical serotonin syndrome combination, and both component sections warn about serotonin syndrome independently.
- Remaining items grouped by component, starting with the Dihexa contraindications: history of metastatic cancer; precancerous lesions under monitoring; pregnancy or breastfeeding (no safety data); paediatric use.
- Dihexa, caution under close medical supervision: bipolar or severe anxiety disorders; epilepsy or seizure history; brain tumours; retinal vascular disease; autoimmune CNS disease.
- Dihexa interactions: other strong neurotrophic agents — Cerebrolysin, Semax / NA-Semax, Selank, NSI-189, BDNF-inducing stacks, high-dose Lion's Mane — anxiety, insomnia, neuroexcitation.
- Dihexa interactions: dopaminergic agents — amplification of amphetamine, methylphenidate, bromantane, and MAO inhibitors, producing agitation, insomnia, sympathetic activation. Methylene blue in this capsule is an MAO inhibitor, which this item covers without saying so.
- Dihexa interactions: growth-factor and regenerative peptides — theoretical additive proliferation signalling with IGF-1 LR3, GH secretagogues (CJC-1295, Ipamorelin), TB-500, BPC-157.
- Dihexa interactions: anti-cancer therapies — potential antagonism with c-MET inhibitors and growth-suppression chemotherapy.
- Methylene Blue contraindications: pregnancy or breastfeeding; G6PD deficiency (haemolytic anaemia risk); active or recent SSRI, SNRI, tricyclic, or MAOI use (serotonin syndrome); severe hepatic or renal disease or dysfunction, given impaired metabolism and elimination.
- Methylene Blue interactions: serotonergic drugs (SSRIs, SNRIs, tricyclics, MAOIs) — serotonin syndrome.
- Methylene Blue interactions: antidepressants — MAO-A inhibition raises hypertensive-crisis and serotonin-syndrome risk with phenelzine and tranylcypromine.
- Methylene Blue interactions: other MAO inhibitors including non-antidepressants such as selegiline — same risks.
- Methylene Blue interactions: anticoagulants and antiplatelets — possible effect on platelet aggregation and coagulation; caution with warfarin and heparin, noted as more common with intravenous administration.
- Methylene Blue interactions: sympathomimetics (epinephrine, dopamine, amphetamine, pseudoephedrine) — hypertension and tachycardia through additive adrenergic stimulation.
- Methylene Blue interactions: CYP1A2 inhibitors and inducers — ciprofloxacin and carbamazepine respectively alter methylene blue levels.
- Methylene Blue interactions: dantrolene — reduced effectiveness in malignant hyperthermia.
- Methylene Blue interactions: caffeine — synergistic CNS stimulation, nervousness, insomnia, tachycardia.
- Tesofensine contraindications: pregnancy or breastfeeding; MAOI use within 14 days; uncontrolled hypertension; significant cardiovascular disease; recent stroke or myocardial infarction; severe arrhythmias; untreated hyperthyroidism; history of serotonin syndrome; severe anxiety disorder; active psychosis or bipolar mania.
- Tesofensine, high risk — do not use: MAO inhibitors (phenelzine, tranylcypromine, high-dose selegiline, isocarboxazid, linezolid).
- Tesofensine, high risk — do not use: severe psychiatric instability — active psychosis, bipolar mania, severe anxiety disorders, uncontrolled mania.
- Tesofensine, high risk — do not use: pregnancy or breastfeeding.
- Tesofensine, high risk — do not use: sympathomimetic stimulants (amphetamines, phentermine, methylphenidate, ephedrine, high caffeine) — tachycardia, hypertension, arrhythmia, anxiety, panic.
- Tesofensine, high risk — do not use: GLP medications, with the instruction not to combine GLP medications with each other.
- Tesofensine, moderate risk under close supervision: GLP-1/GIP/glucagon receptor agents — excessive appetite suppression, nausea amplification, dehydration, resting tachycardia.
- Tesofensine, moderate risk: GH secretagogues (Ipamorelin, Sermorelin, Tesamorelin, CJC-1295) — monitor fasting glucose and sleep quality, watch for cortisol activation.
- Tesofensine, moderate risk: IGF-1 LR3 — glucose instability, appetite dysregulation, headaches.
- Tesofensine, moderate risk: stimulatory / neuroactive peptides, with Dihexa named alongside Semax, Selank, and Cerebrolysin — additive dopaminergic activity producing anxiety and/or overfocus. Dihexa is a component of this capsule, so this combination is flagged against the capsule itself.
- Tesofensine, moderate risk: thyroid-active compounds — additive metabolic stimulation causing palpitations, heat intolerance, excessive weight loss.
- Tesofensine, caution under close medical supervision: controlled hypertension; baseline tachycardia above 90 bpm; insomnia disorders; ADHD medications; anxiety disorders; migraine disorders; poorly controlled diabetes.
- Tesofensine, serotonin syndrome: described as a serious reaction from high serotonin levels, ranging from shivering and diarrhoea to muscle rigidity, fever, seizures, and death, most commonly from combining two serotonergic medications, with some illicit drugs and dietary supplements also implicated.
- Tesofensine, serotonin syndrome features: agitation or restlessness, insomnia, confusion, tachycardia and hypertension, mydriasis, loss of coordination or muscle twitching, diaphoresis, diarrhoea, headache, shivering, piloerection.
- Tesofensine, severe serotonin syndrome: high fever, tremor, seizures, irregular heartbeat, unconsciousness.
- Tesofensine, serotonergic agents — SNRIs: desvenlafaxine (Pristiq), levomilnacipran (Fetzima), milnacipran (Savella), duloxetine (Cymbalta, Drizalma Sprinkle), venlafaxine (Effexor XR).
- Tesofensine, serotonergic agents — SSRIs: citalopram (Celexa), fluoxetine (Prozac), fluvoxamine (Luvox), escitalopram (Lexapro), paroxetine (Paxil, Pexeva, Brisdelle), sertraline (Zoloft).
- Tesofensine, serotonergic agents — bupropion (Zyban, Wellbutrin SR, Wellbutrin XL).
- Tesofensine, serotonergic agents — tricyclic antidepressants such as amitriptyline and nortriptyline (Pamelor).
- Tesofensine, serotonergic agents — MAOIs such as isocarboxazid (Marplan) and phenelzine (Nardil).
- Tesofensine, serotonergic agents — anti-migraine medications: carbamazepine (Tegretol, Carbatrol), valproic acid, and triptans including almotriptan, naratriptan (Amerge), sumatriptan (Imitrex, Tosymra).
- Tesofensine, serotonergic agents — opioid analgesics: codeine, fentanyl (Duragesic, Abstral), hydrocodone (Hysingla ER), meperidine (Demerol), oxycodone (Oxycontin, Roxicodone), tramadol (Ultram, ConZip).
- Tesofensine, serotonergic agents — lithium (Lithobid).
- Tesofensine, serotonergic agents — illicit drugs: LSD, ecstasy, cocaine, amphetamines.
- Tesofensine, serotonergic agents — herbal supplements: St John's wort, ginseng, nutmeg.
- Tesofensine, serotonergic agents — OTC cough and cold preparations containing dextromethorphan (Delsym).
- Tesofensine, serotonergic agents — antiemetics: granisetron (Sancuso, Sustol), metoclopramide (Reglan), droperidol (Inapsine), ondansetron (Zofran).
- Tesofensine, serotonergic agents — linezolid (Zyvox). Note this also appears on the MAOI "do not use" list, since it is a weak MAOI.
- Tesofensine, serotonergic agents — ritonavir (Norvir).
Side effects
- Side effects are grouped by compound below, starting with Dihexa: anxiety.
- Dihexa: a change in how things taste.
- Dihexa: insomnia.
- Dihexa: irritability.
- Dihexa: mood swings.
- Dihexa: nausea.
- Dihexa: headache.
- Dihexa: mental overstimulation.
- Dihexa: sensitivity to light.
- Dihexa: racing thoughts.
- Dihexa: increased focus that borders on agitation, and emotional intensity.
- Methylene Blue: mild nausea.
- Methylene Blue: blue or green urine.
- Methylene Blue: blue or green tongue and saliva.
- Methylene Blue: headache, usually at higher doses.
- Methylene Blue: insomnia.
- Methylene Blue: restlessness.
- Methylene Blue: sweating.
- Methylene Blue: dizziness.
- Methylene Blue: anxiety or jitteriness.
- Methylene Blue: a fast heart rate.
- Methylene Blue: raised blood pressure.
- Methylene Blue: tremor — shaking.
- Methylene Blue: overactive reflexes.
- Methylene Blue: agitation.
- Methylene Blue: haemolytic anaemia — the destruction of red blood cells. It increases oxidative stress in red blood cells lacking the protective molecule NADPH, and is particularly a risk for anyone with G6PD deficiency.
- Methylene Blue: serotonin syndrome. It blocks MAO-A, the enzyme that breaks down serotonin, so combined with other drugs that raise serotonin — SSRIs, SNRIs, MAOIs, tricyclic antidepressants — it can trigger this. Symptoms: overheating, agitation, increased reflexes, tremors, muscle rigidity, confusion or delirium, a fast heart rate, seizures, and swings in blood pressure. This is a medical emergency.
- Methylene Blue: methemoglobinemia. It is used to treat this condition, but overuse or the wrong dose can make it worse in some situations, particularly with other blood disorders, leaving the blood unable to deliver enough oxygen.
- Methylene Blue: heart and blood vessel problems — a fast heart rate and high blood pressure, especially at high doses or in people with an existing heart condition.
- Methylene Blue: nerve toxicity — seizures, confusion, or psychosis at very high doses, particularly when given intravenously or used off-label for brain protection or cognitive enhancement.
- Tesofensine: constipation.
- Tesofensine: diarrhoea.
- Tesofensine: dry mouth.
- Tesofensine: headache.
- Tesofensine: increased blood pressure.
- Tesofensine: raised heart rate.
- Tesofensine: insomnia.
- Tesofensine: nausea.
- Tesofensine: decreased appetite.
- Tesofensine: anxiety or irritability.
- Tesofensine: dizziness.
- Look at how much these three lists overlap. Insomnia, anxiety, headache, nausea, agitation and a raised heart rate appear under two or three of the compounds. In one capsule those effects do not stay separate — they add together.
- Side effects enumerated per component, grouped below, beginning with Dihexa: anxiety; change of taste; insomnia; irritability; mood swings; nausea; headache; mental overstimulation; light sensitivity; racing thoughts; increased focus bordering on agitation and emotional intensity.
- Methylene Blue: mild nausea.
- Methylene Blue: blue/green urine.
- Methylene Blue: blue/green tongue and saliva.
- Methylene Blue: headache, usually at higher doses.
- Methylene Blue: insomnia.
- Methylene Blue: restlessness.
- Methylene Blue: sweating.
- Methylene Blue: dizziness.
- Methylene Blue: anxiety / jitteriness.
- Methylene Blue: tachycardia.
- Methylene Blue: elevated blood pressure.
- Methylene Blue: tremor.
- Methylene Blue: hyperreflexia.
- Methylene Blue: agitation.
- Methylene Blue: haemolytic anaemia — increased oxidative stress in erythrocytes lacking NADPH protection, particularly in G6PD deficiency.
- Methylene Blue: serotonin syndrome via MAO-A inhibition combined with serotonergic agents. Listed features: hyperthermia, agitation, hyperreflexia, tremor, muscle rigidity, confusion or delirium, tachycardia, seizures, blood-pressure lability.
- Methylene Blue: methemoglobinemia, paradoxically inducible on overuse or inappropriate dosing, especially with concurrent blood disorders.
- Methylene Blue: cardiovascular — tachycardia and hypertension at high dose or with pre-existing cardiac disease.
- Methylene Blue: neurotoxicity — seizures, confusion, or psychosis at very high doses, particularly intravenous or off-label neuroprotective use.
- Tesofensine: constipation; diarrhoea; dry mouth; headache; increased blood pressure; elevated heart rate; insomnia; nausea; decreased appetite; anxiety or irritability; dizziness.
- The three lists overlap heavily on insomnia, anxiety, headache, nausea, agitation, tachycardia, and hypertension, and in a fixed-dose combination those are additive rather than parallel. The overlap is also the clinical presentation of early serotonin syndrome — tremor, hyperreflexia, agitation, diaphoresis, tachycardia — which makes distinguishing ordinary tolerability from the dangerous reaction harder here than with any component alone.
User reports
User reports are individual experiences submitted by site visitors. They are not medical advice, are not verified for accuracy, and do not reflect Amino Reference's views. Read the evidence section above and talk to a clinician. Full disclaimer.
Stacking
The nootropic component, sold on its own in 5 mg capsules — the same amount as in this blend. Its page has a proper cycle length, which this one does not, and it lists MAO inhibitors as a caution.
The synaptogenic component as a standalone at the same 5 mg, with a defined 8–12 week cycle, fasted dosing, and a 5–20 mg range this blend fixes at the bottom. Its interactions section flags dopaminergic agents and MAO inhibitors, both of which describe its co-components here.
The mitochondrial component, sold on its own at 25 mg — half the amount in this blend. Its page gives a cycle length and washout, which this page does not.
The bioenergetic component as a standalone at 25 mg, half this blend's content, with a 4–8 week cycle and 2–4 week washout. It is also the MAO-A inhibitor in this combination, which is the pharmacological crux of the whole product.
The weight loss component, sold on its own at the same 500 mcg strength. Its own page names Dihexa as a compound to combine only with extreme caution, and lists MAO inhibitors under do-not-use — and this capsule contains both.
The triple reuptake inhibitor as a standalone at the identical 500 mcg. Its page's own risk lists exclude MAO inhibitors outright and place Dihexa under moderate-risk additive dopaminergic activity. This capsule combines it with both, which is why that page is worth reading before this one.
Dosing figures have been reviewed and units are recomputed from the stated protocol.